-G C Fonarow Researcher Activity Profile

Research Author Detailed Information 

G C Fonarow Publication Rate By Year

G C Fonarow has published 1 paper(s) in 2000, 2 paper(s) in 2006, 23 paper(s) in 2007, 24 paper(s) in 2008, for a total of 50 research publications in total.

G C Gc Fonarow Author Information

LAST NAME: fonarow

FIRST NAME: G C

INITIALS: gc

AFFILIATION:

Papers

G C Fonarow's Publication Record

1. Interscan variation in coronary artery calcium quantification in a large asymptomatic patient population. Year Published: 2000
Department of Radiology, 1A71 School of Medicine, University of Utah School of Medicine, Salt Lake City 84132, USA.
2. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Year Published: 2007
Division of Cardiology, Feinberg School of Medicine, Northwestern University, Galter 10-240, 201 E Huron Street, Chicago, IL 60611, USA. m-gheorghiade@northwestern.edu
3. Total cholesterol levels and mortality risk in nonischemic systolic heart failure. Year Published: 2006
Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, Los Angeles, CA, USA.
4. Heart failure with preserved ejection fraction: disturbing trends. Year Published: 2007
David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
5. Racial and survival paradoxes in chronic kidney disease. Year Published: 2007
Harold Simmons Center for Kidney Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA. kamkal@ucla.edu
6. Quality indicators for the care of heart failure in vulnerable elders. Year Published: 2007
Veterans Affairs Palo Alto Health Care System Department of Medicine, Stanford University, Stanford, CA 94303, USA. heiden@stanford.edu
7. Performance measures for patients hospitalized with heart failure: are they predictive of clinical outcomes? Year Published: 2007
From the University of California Los Angeles Medical Center, Los Angeles, CA.
8. Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes. Year Published: 2007
Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA. srockson@cvmed.stanford.edu
9. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Year Published: 2007
Johns Hopkins School of Medicine, Baltimore, MD, USA.
10. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation. Year Published: 2007
UCLA Cardiac Arrhythmia Center, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
11. Reverse Epidemiology beyond Dialysis Patients: Chronic Heart Failure, Geriatrics, Rheumatoid Arthritis, COPD, and AIDS. Year Published: 2007
Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California, USA.
12. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. Year Published: 2007
Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California 90095-1679, USA.
13. Assessing clinical risk prediction tools. Year Published: 2007
14. Quality indicators for the care of heart failure in vulnerable elders. Year Published: 2007
Veterans Affairs Palo Alto Health Care System Department of Medicine, Stanford University, Stanford, CA 94303, USA. heiden@stanford.edu
15. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Year Published: 2007
Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California, USA. thorwich@mednet.ucla.edu
16. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Year Published: 2007
Johns Hopkins School of Medicine, Baltimore, MD, USA.
17. Assessing clinical risk prediction tools. Year Published: 2007
18. Relation of Low Hemoglobin and Anemia to Morbidity and Mortality in Patients Hospitalized With Heart Failure (Insight from the OPTIMIZE-HF Registry). Year Published: 2008
Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio.
19. Usefulness of B-Type Natriuretic Peptide and Cardiac Troponin Levels to Predict In-Hospital Mortality from ADHERE. Year Published: 2008
Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California.
20. Performance measures for patients hospitalized with heart failure: are they predictive of clinical outcomes? Year Published: 2007
University of California Los Angeles Medical Center, Los Angeles, CA 90095-1679, USA. gfonarow@mednet.ucla.edu
21. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Year Published: 2006
Ahmanson/University of California-Los Angeles Cardiomyopathy Center, University of California-Los Angeles Medical Center, Los Angeles, CA 90095, USA. gfonarow@mednet.ucla.edu
22. Acute decompensated heart failure: challenges and opportunities. Year Published: 2008
Ahmanson-UCLA Cardiomyopathy Center, UCLA Division of Cardiology, Los Angeles, California, USA.
23. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Year Published: 2008
Wayne State University, Detroit, Mich, USA. jghali@med.wayne.edu
24. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Year Published: 2007
Department of Medicine, University of California-Los Angeles Medical Center, 10833 LeConte Ave, Room 47-123 CHS, Los Angeles, CA 90095-1679, USA. gfonarow@mednet.ucla.edu
25. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. Year Published: 2007
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA. adrian.hernandez@duke.edu
26. Performance measures for patients hospitalized with heart failure: are they predictive of clinical outcomes? Year Published: 2007
University of California Los Angeles Medical Center, Los Angeles, CA 90095-1679, USA. gfonarow@mednet.ucla.edu
27. Epidemiology and risk stratification in acute heart failure. Year Published: 2008
Ahmanson-University of California Los Angeles (UCLA) Cardiomyopathy Center, University of California Los Angeles, Los Angeles, CA.
28. Heart failure disease management programs: A cost-effectiveness analysis. Year Published: 2008
Brigham and Women's Hospital, Boston, MA.
29. Epidemiology and risk stratification in acute heart failure. Year Published: 2008
Ahmanson-University of California Los Angeles Cardiomyopathy Center, University of California Los Angeles, Los Angeles, CA, USA. gfonarow@mednet.ucla.edu
30. Heart failure disease management programs: a cost-effectiveness analysis. Year Published: 2008
Brigham and Women's Hospital, Boston, MA 02115, USA. dcchan@partners.org
31. Hyponatremia in acute heart failure syndromes: a potential therapeutic target. Year Published: 2008
Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
32. Hyponatremia in acute heart failure syndromes: a potential therapeutic target. Year Published: 2008
Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
33. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Year Published: 2007
Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California, USA. thorwich@mednet.ucla.edu
34. Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes. Year Published: 2007
Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA. srockson@cvmed.stanford.edu
35. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Year Published: 2008
Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio, USA. youngj@ccf.org
36. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Year Published: 2008
Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California, USA. gfonarow@mednet.ucla.edu
37. Acute decompensated heart failure: challenges and opportunities. Year Published: 2008
Ahmanson-UCLA Cardiomyopathy Center, UCLA Division of Cardiology, Los Angeles, California, USA.
38. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. Year Published: 2007
Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California 90095-1679, USA.
39. Epidemiology and risk stratification in acute heart failure. Year Published: 2008
Ahmanson-University of California Los Angeles Cardiomyopathy Center, University of California Los Angeles, Los Angeles, CA, USA. gfonarow@mednet.ucla.edu
40. Heart failure disease management programs: a cost-effectiveness analysis. Year Published: 2008
Brigham and Women's Hospital, Boston, MA 02115, USA. dcchan@partners.org
41. Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM). Year Published: 2008
University of California, Davis Medical Center, Sacramento, CA, USA. dbdiercks@ucdavis.edu
42. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Year Published: 2008
Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio, USA. youngj@ccf.org
43. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Year Published: 2008
Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California, USA. gfonarow@mednet.ucla.edu
44. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Year Published: 2008
Wayne State University, Detroit, Mich, USA. jghali@med.wayne.edu
45. Cardiorenal interactions: insights from the ESCAPE trial. Year Published: 2008
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
46. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation. Year Published: 2007
UCLA Cardiac Arrhythmia Center, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
47. Comprehensive adrenergic blockade post myocardial infarction left ventricular dysfunction. Year Published: 2008
Geffen School of Medicine at UCLA, UCLA Medical Center, Los Angeles, CA, USA. gfonarow@mednet.ucla.edu
48. Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure. Year Published: 2008
Div. of Cardiology, 47-123 CHS, UCLA Dept. of Medicine, 10833 Le Conte Ave., Los Angeles, CA 90095. hmiddlekauff@mednet.ucla.edu).
49. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. Year Published: 2008
University of Alabama at Birmingham, and VA Medical Center, Birmingham, Alabama.
50. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. Year Published: 2008
University of Alabama at Birmingham, and VA Medical Center, Birmingham, Alabama 35294-2041, USA. aahmed@uab.edu